Literature DB >> 6107151

Renal function in patients with essential hypertension receiving nadolol.

H J Waal-Manning, C H Hobson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6107151      PMCID: PMC1713285          DOI: 10.1136/bmj.281.6237.423-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  2 in total

1.  Changes in glomerular filtration rate during long-term treatment with propranolol in patients with arterial hypertension.

Authors:  H Ibsen; P Sederberg-Olsen
Journal:  Clin Sci       Date:  1973-02       Impact factor: 6.124

2.  Deterioration in renal function after beta-blockade in patients with chronic renal failure and hypertension.

Authors:  D J Warren; C P Swainson; N Wright
Journal:  Br Med J       Date:  1974-04-27
  2 in total
  5 in total

Review 1.  Beta-blockers and renal function.

Authors:  R Wilkinson
Journal:  Drugs       Date:  1982-03       Impact factor: 9.546

2.  Intrinsic sympathomimetic activity of cardioselective beta-adrenoceptor blockers and effects on renal function.

Authors:  I G Mackay; A M Macnicol; H J Smith; A D Cumming; M L Watson
Journal:  Br J Clin Pharmacol       Date:  1985-09       Impact factor: 4.335

3.  Nadolol in essential hypertension: effect on ambulatory blood pressure, renal haemodynamics and cardiac function.

Authors:  A G Dupont; P Vanderniepen; A M Bossuyt; M H Jonckheer; R O Six
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

4.  Effects of nadolol and propranolol on renal function in hypertensive patients with moderately impaired renal function.

Authors:  K K Pun; C K Yeung; M K Chan
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

5.  Antihypertensive and renal haemodynamic effects of atenolol and nadolol in elderly hypertensive patients.

Authors:  W G O'Callaghan; M S Laher; K McGarry; E O'Brien; K O'Malley
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.